Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1

被引:89
|
作者
Tan, A
Bitterman, P
Sonenberg, N
Peterson, M
Polunovsky, V
机构
[1] Univ Minnesota, Sch Med, Dept Pulm Med, Allergy & Crit Care Div, Minneapolis, MN 55255 USA
[2] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada
关键词
Myc; eIF4E; apoptosis; cyclin D1; translation;
D O I
10.1038/sj.onc.1203446
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ectopically expressed eukaryotic translation initiation factor 4E (eIF4E) stimulates cell proliferation, suppresses apoptosis in growth factor restricted cells, and induces malignant transformation in primary rodent fibroblasts when coexpressed with protooncogene myc. We report here that eIF4E rescued rat embryo fibroblasts ectopically expressing c-Myc (REF/Myc) from genotoxic and non-genotoxic cytostatic drugs and identify cyclin D1 as a downstream effector in the antiapoptotic mechanism, In clones of REF/Myc ectopically expressing eIF4E, resistance to apoptosis paralleled steady state levels of cyclin D1. Stable expression of cyclin D1 in REF/Myc inhibited apoptosis in response to a broad range of cell cycle specific cytostatic agents, Partial loss-of-cyclin D1 function in REF/Myc ectopically expressing eIF4E (REF/Myc/4E) significantly increased chemosensitivity; either soluble antisense cyclin D1 oligomers or transfection with a dominant negative cyclin D1 mutant that prevents translocation of cyclin D-dependent kinases to the nucleus, significantly blunted the antiapoptotic effect of eIF4E, These data directly link eIF4E rescue from cytostatic drugs to cyclin D1, Since overexpression of eIF4E and cyclin D1 is observed in many aggressive forms of chemoresistant cancers, these findings provide insight into possible mechanisms responsible for this biological behavior.
引用
收藏
页码:1437 / 1447
页数:11
相关论文
共 50 条
  • [1] Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1
    Annie Tan
    Peter Bitterman
    Nahum Sonenberg
    Mark Peterson
    Vitaly Polunovsky
    Oncogene, 2000, 19 : 1437 - 1447
  • [2] EUKARYOTIC TRANSLATION INITIATION-FACTOR 4E REGULATES EXPRESSION OF CYCLIN D1 AT TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL LEVELS
    ROSENWALD, IB
    KASPAR, R
    ROUSSEAU, D
    GEHRKE, L
    LEBOULCH, P
    CHEN, JJ
    SCHMIDT, EV
    SONENBERG, N
    LONDON, IM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (36) : 21176 - 21180
  • [4] Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E
    Rousseau, D
    Kaspar, R
    Rosenwald, I
    Gehrke, L
    Sonenberg, N
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (03) : 1065 - 1070
  • [5] Cyclin D1 mediates survival signaling downstream of translation initiation factor 4E in fibroblasts expressing deregulated c-MYC.
    Tan, A
    Bitterman, PB
    Sonenberg, N
    Polunovsky, VA
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 1436 - 1436
  • [6] ELEVATED LEVELS OF CYCLIN D1 PROTEIN IN RESPONSE TO INCREASED EXPRESSION OF EUKARYOTIC INITIATION-FACTOR 4E
    ROSENWALD, IB
    LAZARISKARATZAS, A
    SONENBERG, N
    SCHMIDT, EV
    MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (12) : 7358 - 7363
  • [7] Role of cyclin D1 as a downstream effector of translation initiation factor 4E mediated fibroblast survival.
    Tan, A
    Polunovsky, VA
    Bitterman, PB
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (07) : A397 - A397
  • [8] Role of cyclin D1 as a downstream effector of translation initiation factor 4E mediated fibroblast survival.
    Tan, A
    Polunovsky, VA
    Bitterman, PB
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 1110 - 1110
  • [9] Eukaryotic initiation factor 4E
    Goodfellow, Ian G.
    Roberts, Lisa O.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (12): : 2675 - 2680
  • [10] Targeting the eukaryotic translation initiation factor 4E for cancer therapy
    Graff, Jeremy R.
    Konicek, Bruce W.
    Carter, Julia H.
    Marcusson, Eric G.
    CANCER RESEARCH, 2008, 68 (03) : 631 - 634